Bellerophon Therapeutics, Inc.BLPH
Market cap
$146.79K
P/E ratio
| 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | |
| Stock-based compensation | 2 | 3 | 3 | 3 | 2 | 2 | 1 | 1 |
| Cash from operations | -46 | -17 | -16 | -15 | -13 | -20 | -23 | -18 |
| Capital expenditures | -0 | -0 | - | - | - | - | - | - |
| Cash from investing | -18 | 12 | 3 | 3 | - | - | - | - |
| Cash from financing | 54 | 13 | 28 | 0 | 6 | 58 | - | -0 |
| Free cash flow | - | - | - | - |